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The protein kinase C (PKC) activating phorbol esters are known to prevent the decay of mRNA of several cytokines and proto-oncogenes. To 
examine whether the phorbol ester signal is continuously required for this stabilizing effect, THP-1 monocytic cells were stimulated either with 
phorbol 12,13-dibutyrate (PDBu), which can be removed from the cells by washings, or with the more hydrophobic phorbol 12-myristate 13-acetate 
(PMA). Both of these stimuli induced high levels of interleukin-l,!I (IL-I/?) mRNA. When the cells were washed at the peak of the IL-lp mRNA 
expression, this mRNA decayed rapidly in the PDBu stimulated cells while in PMA stimulated cells the mRNA levels were not affected. Moreover, 
this mRNA degradation induced by the removal of PDBu could be inhibited by readdition of the phorbol ester. This restabilization could be 
prevented by pharmacologic inhibitors of PKC, but not by inhibiting protein or RNA synthesis. Thus these data suggest hat the phorbol ester 
must be continuously present o exert its mRNA stabilizing effect and that its effect is PKC-mediated but does not require active protein or RNA 
synthesis. 
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1. INTRODUCTION 
The regulation of mRNA turnover plays a major role 
in the control of gene expression. Many cytokine and 
proto-oncogene mRNAs are unstable due to c&acting 
sequences. They contain a single or multiple copies of 
an adenosine-uridine (AU)-rich sequence (AUUUA) in 
their 3’ untranslated regions [l-3] and this sequence, 
originally characterized in granulocyte-macrophage 
colony stimulating factor gene, has been shown to con- 
fer instability upon p-globin mRNA if it is fused to- 
gether with the /I-globin gene [l]. Recent reports indi- 
cate that protein kinase C (PKC), a calcium and phos- 
pholipid-dependent enzyme activated by diacylglycerol 
(DAG) [4], is involved in controlling of the stability of 
TNF-a [5] and IL-2 [6] mRNA. The target sequence of 
the PKC action is, at least in some cases, the AUUUA 
sequence: it has been shown that phorbol esters activate 
a cytoplasmic protein which complexes to a variety of 
labile mRNAs containing this sequence [7]. 
Now we have used the phorbol ester induced expres- 
sion of interleukin-lg mRNA (containing multiple cop- 
ies of the AUUA sequence [8]) as a model to study the 
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role of the phorbol ester mediated activation of PKC in 
mRNA stabilization. Specifically, we wanted to exam- 
ine whether the phorbol ester must be continuously 
present o exert its mRNA stabilizing effect and whether 
this effect requires active protein synthesis. 
2. MATERIALS AND METHODS 
2.1. Cell cultures 
The THP-1 cell line was obtained from the American Type Culture 
Collection (Rockville, MD). Cells were cultured in RPM1 1640 me- 
dium (Flow Labs., Irvine, Scotland, UK) containing 10 mM HEPES, 
2 mM L-glutamine, 70 mM 2-mercapto-ethanol, antibiotics and 10% 
fetal calf serum (Flow Labs.). The cells were tested monthly for myco- 
plasma and were found to be negative. During the exponential growth 
phase, cells at the density of 0.5 x 106/ml were stimulated in 75 cm’ 
tissue culture flasks (Costar, Cambridge, MA) with the indicated con- 
centrations of phorbol 12-myristate 13-acetate (PMA), phorbol 12,13- 
dibutyrate (PDBu), 1,2-dioctanoyl-sn-glycerol C8:O(DOG), cyclo- 
heximide (CHX) and actinomycin D (AD) all from Sigma Chemical 
Co. (St. Louis, MO) and calcium ionophore A23187 (Calbiochem, La 
Jolla, CA). Protein kinase inhibitors H-7 (I-(5isoquinolone-sulfonyl)- 
2-methylpiperazine dihydrochloride) and HA1004 (N-(2-guanidi- 
noethylsulfonamide hydrochloride) were purchased from Seikagaku 
Kogyo Co. (Tokyo, Japan). After the indicated times, the cultures 
were harvested and the washings were done with PBS (phosphate 
buffered saline; pH 7.4) and the cells were used for mRNA analysis. 
2.2. RNA isolations and analysis 
At the times indicated, cells were harvested and poly(A)’ RNA was 
extracted from 10’ cells. The poly(A)’ RNA was bound to oligo(dT) 
cellulose (Boehringer-Mannheim GmbH, Mannheim, Germany)‘di- 
rectly from cell lysates and eluted as described [9]. The isolated RNA 
was quantitated spectrophotometrically and samples containing the 
same amount of RNA were size-fractionated on 1.2% formaldehyde- 
agarose gels and transferred to a nylon membrane (Pall, Glen Cove, 
Volume 3 15, number 1 FEBS LETTERS January 1993 
IL-1 beta 
GAPDH 
Fig. 1. The effect of washing on PDBu or PMA induced IL-l/I mRNA 
expression. THP-1 cells were stimulated with either 100 @ml PDBu 
or 10 ng/ml PMA for 19 h. Then the cells in the groups marked with 
‘w’ were extensively washed with PBS and the cells resuspended to a 
fresh medium. Some cultures received AD (5 pg/ml). The last two 
groups were restimulated with 100 &ml PDBU with or without the 
PKC-inhibitor H-7. After 5 h of incubation the cells were harvested 
and the mRNA was isolated. mRNA samples (5 pup) were fractionated 
on agarose gel, transferred to a nylon membrane, and then hybridized 
to “P-labeled IL-l/I and GAPDH cDNA probes. 
NY). The IL-l/? cDNA probe (HU-IL-IS, pcDSRa) used was kindly 
provided by Dr. Kari Varkila (DNAX Research Institute, Palo Alto, 
CA). The RNA levels in the nylon membranes were also compared 
with the signal from a probe to a constantly expressed mRNA, glycer- 
aldehyde phosphate dehydrogenase (pRGAPDH-13). The probes 
were labeled with [a-32P]dCTP (3000 Wmol, Amersham Interna- 
tional, Amersham, UK) by a random-primed DNA labelhng kit 
(Boehringer-Mannheim GmbH). Prehybridizations and hybridiza- 
tions were performed in a solution containing 50% formamide, 5 x 
Denhardt’s olution, 5 x SSPE and 0.5% SDS. Filters were washed in 
1 x SSC plus 0.1% SDS 2 times for 30 min at room temperature and 
at 60°C for 30 min. Then the filters were exposed to Kodak AR 
X-Omat films at -70°C with intensifying screens. Radioactive signals 
were quantitated from the autoradiograms with a densitometric scan- 
ner (Helena Laboratories, Beaumont, TX). 
3. RESULTS 
To analyze whether the phorbol ester mediated signal 
is required continuously to prevent the decay of the 
preformed mRNA we used the relatively water-soluble 
PDBu, which can be removed from the cells by washing 
[lo-121. Both PDBu and PMA (the more hydrophobic 
form) induced a strong IL-lp mRNA expression in the 
THP-I cells (Fig. 1). With both of these agents maximal 
IL-IS mRNA levels could be detected ca 24 h after the 
stimulation (data not shown). When the stimulated cells 
were extensively washed 5 h prior to the harvesting, 
IL-1s mRNA levels strongly declined in the PDBu stim- 
ulated cultures but in contrast to this, the PMA induced 
IL-1B mRNA levels were not reduced by this treatment 
(Fig. 1). In fact, the PMA induced IL-l/? mRNA levels 
were somewhat higher after the washing. Blocking of 
the RNA synthesis by AD at the same time did not 
decrease the PDBu induced IL-lp mRNA levels, thus 
suggesting that the observed decline was not due to 
cessation of the transcription but rather due to acceler- 
ated decay of the preformed mRNA. The possible tran- 
scriptional effect on the decline of the IL-l/3 mRNA 
levels was excluded by demonstrating that re-added 
PDBu in the presence of the RNA synthesis inhibitor 
AD totally abolished the washing effect (Fig. 1). 
The half-life of the IL-l/? mRNA after removal of 
PDBu (20 h after the stimulation) was found to be 
clearly less than 2 h (Fig. 2). This is in marked contrast 
to the reported 12 h half-life of the PMA induced IL-lp 
mRNA in these same cells [13]. 
To further characterize the stabilizing signal, the cells 
stimulated for 20 h with PDBu were washed and then 
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Fig. 2. The degradation rate of the PDBu induced IL-l/3 mRNA after 
washing. THP-1 cells were stimulated with 100 ng/ml PDBu for 20 h, 
then washed and AD (5 &ml) was added. The control group was 
harvested immediately and the other groups at the time points indi- 
cated. The mRNA samples (5 pg) were isolated and analyzed as 
described in the legend of Fig. 1 (panel A). Densitometric scanning of 
the data are shown in panel B. The levels of IL-l/Y mRNA in these 
groups were standardized according to the expression of the constant 
gene (GAPDH). 
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Fig. 3. Characterization of the IL-l/3 mRNA restabilizing signal. THP-1 cells were stimulated with 100 @ml PDBu for 20 h, then washed and 
AD (5 pg/ml) was added (PWA-cells). The cells were then incubated either with 100 nM staurosporine, 50 PM or 100 PM H-7 or HA1004 or 10 
&ml CHX for half-an-hour before addition of 100 @ml PDBu. Some PWA groups were stimulated with 100pM DOG in the presence or absence 
of 500 nM A23187 calcium ionophore. The cells were incubated for 4 h and the mRNA samples were isolated and analyzed as in Fig. 1. 
immediately restimulated in the presence of AD. IL-l/I 
mRNA levels were quantitated 5 h later. As already 
shown in Fig. 1, re-added PDBu clearly restabilized the 
IL-Q? mRNA (Fig. 3). Also the structural DAG analog, 
dioctanylglycerol (DOG), which in the presence of cal- 
cium ionophore causes a short-lived PKC activation 
[14], was sufficient for restabilization. Moreover, resta- 
bilization did not require protein synthesis as CHX 
could not prevent the restabilizing effect of PDBu. As 
expected, the PDBu-mediated effect was dependent on 
PKC activity: PKC inhibitors H7 and staurosporine, 
but not the preferential protein kinase A inhibitor HA 
1004, effectively prevented the restabilizing effect of 
PDBu. 
4. DISCUSSION 
The data shown in this report demonstrate that in the 
absence of the phorbol ester the preformed IL-l/I 
mRNA is rapidly degraded and that the mRNA stabi- 
lizing effect of these agents does not require active RNA 
or protein synthesis, but is dependent on the PKC activ- 
ity. 
In different cell types stimulation with phorbol esters 
leads to initial activation and membrane localization of 
PKC, which lasts a few hours and after this time the 
enzymatic activity of PKC declines, probably due to 
proteolytic degradation of this enzyme [4]. In myeloid 
cell lines, e.g. in the THP-1 cells used in these experi- 
ments, this activation induces the cells to differentiate 
to more mature, macrophage-like cells and to express 
various cytokine genes, such as IL-l/? (reviewed in [ 151). 
It is probable that these changes are due to activation 
of the AP-1 transcription factor complex [ 161. Our find- 
ings showing that the phorbol ester must be continu- 
ously present to exert its mRNA stabilizing effect sug- 
gest that this initial PKC activation and the subsequent 
AP-1 induction are not involved in the stabilization 
mechanism. This interpretation is further supported by 
the finding that induction with DOG plus ionophore 
was sufficient to restabilize the IL-l/3 mRNA after 
PDBu removal; this stimulus causes a very short-lived 
PKC activation, which activates the AP-1 enhancer ac- 
tivity only very weakly and does not induce differentia- 
tion [16]. Thus it can be concluded that the mRNA 
stabilizing PKC activity differs from the AP-1 inducing 
PKC activity quantitatively, but it is also possible that 
it is qualitatively different (e.g. representing the activity 
of a different PKC isozyme). 
The mRNA stabilizing mechanism of phorbol esters 
described here is fully compatible with the reported 
mechanism of action of the AU-binding factor (AUBF). 
It is a cytoplasmic protein which can be activated by 
phorbol esters and binds to several mRNAs containing 
this motive [7]. AUBF is posttranslationally activated 
by phosphorylation and de novo protein synthesis is not 
required [ 171 thus being in line with the requirements for 
the phorbol ester mediated stabilizing effect reported 
here. In addition to this, when the effect of PDBu re- 
moval was tested on mRNAs which can be induced by 
phorbol esters in the THP-1 cell line but which do not 
contain the AU-rich sequence (e.g. CD1 lb), no decline 
in the mRNA levels was observed (data not shown). 
Thus the involvement of the AU-rich sequence of the 
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IL-l/3 mRNA in the phorbol ester mediated stabiliza- 
tion seems very likely. 
The data reported here have also some practical im- 
plications. The mRNA half-life measurements done in 
PMA stimulated cells after AD blocking are strongly 
influenced by the stabilizing effect of the PMA remain- 
ing within the cells. This effect could mask or modify 
the influence of other mRNA decay mechanisms. In 
fact, we have recently reported that the degradative 
effect of glucocorticoids on IL- l/3 mRNA [IS] seems to 
be weaker in PMA stimulated human monocytes than 
in bacterial ipopolysaccharide stimulated cells [ 191. 
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